Congratulations to the 2018 winners; Cornelia Landersdorfer (Monash Institute of Pharmaceutical Sciences), Ana Traven (Monash Biomedicine Discovery Institute) and Aleksandra Filipovska (Harry Perkins Institute of Medical Research, UWA).
Leading malaria researcher Professor Leann Tilley and her team have uncovered the mechanism of how frontline antimalarial drug, artemisinin, works and are now working on a promising chemotherapy-based compound to treat patients.
Meet Kirsty Turner, Bio21's Research Support Services Manager, with responsibilities for oversight and support to the Institute’s platform technologies, research groups and industry tenants and most importantly her daughter Alyssa.
Congratulations to Danny Hatters, Malcolm McConville and Jose Villadangos on being the recipients of National Health and Medical Research Council research fellowships.
Meet Jacqueline Heath, Early Career Researcher, Scholz Research Group, Reynolds Laboratory, Oral Health CRC, Bio21 Institute and Melbourne Dental School.
A member of the CRC program, St Vincent’s Institute and Bio21 Institute, University of Melbourne’s Professor Michael Parker and his team contributed to the structural biology of the target proteins KAT6A and KAT6B, as well as the corresponding selective inhibitors.